Le Lézard5h
National survey reveals low understanding of shingles risk factors and lack of concern among those at increased risk
Among those with a chronic condition, concern of getting shingles is low with only 12% highly concerned and 37% somewhat concerned Over 80% of those with a chronic condition have not been informed by ...
Merck’s application for keytruda in HNSCC granted priority review by FDA
Merck (MRK) announced the FDA has accepted for priority review a new supplemental Biologics License Application seeking approval for keytruda – ...
FDA accepts BMS’ Opdivo-Yervoy combo sBLA for colorectal cancer
The US Food and Drug Administration (FDA) has accepted Bristol Myers Squibb’s (BMS) supplemental biologics licence ...